Our exploration into whether HD’s activation of the HNF-1β/DRA signaling pathway was contingent upon its interaction with HNF-1β involved conducting pull-down assays to verify the physical connection between HD and HNF-1β. This evidence concerns the gene SLC26A3 and Huntington disease.